enGene Lays Off 50% of Staff and Stops Patient Enrollment to Save Cash

enGene is reducing its workforce by ~50% and has stopped patient enrollment in three additional LEGEND trial cohorts to preserve cash while focusing on its pivotal data and planned BLA filing.